Current status:
Cancelled Post Market
Current status date:
2016-10-25
DIN:
02238319
Electronic product monograph is not available
Company:
PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada
H4P 2T4
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N04BD01 SELEGILINE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
SELEGILINE HYDROCHLORIDE
|
5 MG
|